deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL NCT00222235

Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)

Sponsor: Nathan Kline Institute for Psychiatric Research

Conditions Schizoaffective Disorder Schizophrenia
Interventions d-cycloserine glycine placebo
Updated 6 times since 2017 Last updated: Aug 15, 2019 Started: Jan 31, 2000 Primary completion: Jun 30, 2004 Completion: Jun 30, 2004
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Schizoaffective Disorder and Schizophrenia, this trial is completed. The trial is conducted by Nathan Kline Institute for Psychiatric Research and has accumulated 6 data snapshots since 2000. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshotCompleted~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  5. Jun 2018 — Sep 2019 [monthly]

    Completed PHASE2_PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nathan Kline Institute for Psychiatric Research
  • National Institute of Mental Health (NIMH)
  • Sarah Herzog Hospital
  • The Zucker Hillside Hospital
  • University of California, Los Angeles
  • University of Maryland, Baltimore
  • University of Maryland, College Park
Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations